Centers & Services

Department of Allergy and Respiratory Medicine

About Us

We provide diagnosis and treatment for malignant tumors including those related to lung cancer, bronchial asthma, pulmonary emphysema, pulmonary fibrosis, lung disorder associated with collagen disease, granulomatous lung disease, diffuse panbronchiolitis, and chronic respiratory failure. We are specialized most in the treatment of lung cancer among thoracic neoplastic diseases, reporting excellent treatment outcomes by global standards. We also perform cutting-edge clinical studies and clinical trials such as multidrug therapy using state-of-the-art anticancer agents, high-dose chemotherapy in combination with autologous peripheral blood stem cell transplantation, multidisciplinary treatment by the combination of chemotherapy with surgery or chest irradiation, and novel molecular targeted drugs. In addition, cancer chemotherapy is performed for widely various tumor systems such as breast cancer, ovarian cancer, germ cell tumor, soft tissue tumor, gastric cancer, colon cancer, as well as head and neck tumors. For respiratory and allergic diseases, therapeutic strategy is based on the results from respiratory function test or bronchial fiberscope. Attacks are preventable effectively in bronchial asthma patients by the early introduction of steroid inhalers. For pulmonary emphysema, the applicability of surgery is judged carefully. At the same time, home oxygen therapy is encouraged for patients in a state of chronic respiratory failure.

Our physicians

Director, Department of Allergy and Respiratory Medicine

Katsuyuki Kiura, Professor
[Respiratory medicine, clinical oncology and molecular targeted therapy]

Staff

Arihiko Kanehiro Associate Professor [Respiratory medicine, allergy and asthma]
Kadoaki Ohashi Assistant Professor [Respiratory medicine, clinical oncology and molecular targeted therapy]
Eiki Ichihara Assistant Professor [Respiratory medicine, Clinical oncology and molecular targeted therapy, Palliative Medicine]
Takashi Ninomiya Assistant Professor [Respiratory medicine, clinical oncology and molecular targeted therapy]
Fumihiro Mitsunobu Professor(Department of Longevity and social Medicine) [Respiratory medicine and asthma]
Nobuaki Miyahara Professor (Department of Health Science) [Respiratory medicine, allergy and asthma]
Katsuyuki Hotta Professor (Center for Innovative Clinical Medicine) [Clinical oncology and molecular targeted therapy]
Masahiro Tabata Associate Professor (Director, Center for Clinical Oncology) [Clinical oncology and molecular targeted therapy]
Toshio Kubo Assistant Professor (Center for Clinical Oncology) [Clinical oncology and palliative care, molecular targeted therapy]
Kammei Rai Assistant Professor (Department of General Medicine ) [Respiratory medicine, Clinical oncology and molecular targeted therapy]
Hideki Katayama Assistant Professor (Department of Palliative Medicine) [Clinical oncology, palliative medicine and molecular targeted therapy]
Kenji Nishii Part-Time Lecturer [Outpatient smoking cessation program]

*Specialty shown in [ ]

Weekly schedule of outpatient clinic

  Monday Tuseday Wednesday Thursday Friday
Outpatient physicians Professor Associate Professor Assistant Professor Professor Assistant Professor Associate Professor Assistant Professor Associate Professor Assistant Professor Professor Assistant Professor
Weekly schedule of outpatient physicians AM Respiratory medicine and allergy Respiratory medicine and allergy Respiratory medicine Respiratory medicine and allergy Respiratory medicine, allergy and outpatient smoking cessation program
PM Respiratory medicine and allergy (with appointment) Respiratory medicine and allergy (with appointment) Respiratory medicine (with appointment) Respiratory medicine and allergy (with appointment) Respiratory medicine and allergy (with appointment)

Medical care system

The outpatient clinic by specialists is available every day. For hospital treatment, the treatment policy and observations of each patient are discussed every week. A joint conference is held regularly with the Department of General Thoracic Surgery and Department of Radiology to discuss comprehensive treatment policies.

Main testing methods and explanation

Pulmonary function test

Subdivisions of total lung capacity, flow volume curve, and lung diffusing capacity evaluation, etc. are used for the diagnosis and therapeutic effect determination of obstructive pulmonary disease and interstitial lung disease.
They are also useful for the early detection of treatment-related lung disorder in patients undergoing chemotherapy or radiotherapy such as for lung cancer.

Bronchial fiberscopy

Histological and cytological examinations are conducted for patients with malignant tumors such as lung cancer to obtain a definitive diagnosis. Cell typing in bronchoalveolar lavage fluid, surface marker analysis and cytokine measurement, in addition to histology, are used for the clarification of pathological conditions and for the determination of an appropriate treatment policy in patients with diffuse pulmonary disease such as sarcoidosis. We have also performed bronchoscopy actively in over 250 cases as well as bronchoscopy with sonographic functions such as EBUS-TBNA (Endobronchial ultrasound-guided transbronchial needle aspiration and sheath-guided biopsy). Less-invasive diagnosis has become possible for lesions in lymph nodes in the center of the chest, which had previously been obtainable only by surgery. A novel rapid diagnosis system has also been established, producing diagnoses with improved accuracy.